125 related articles for article (PubMed ID: 7956313)
21. The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
Halpert G; Halperin Sheinfeld M; Monteran L; Sharif K; Volkov A; Nadler R; Schlesinger A; Barshak I; Kalechman Y; Blank M; Shoenfeld Y; Amital H
Clin Exp Immunol; 2021 Mar; 203(3):375-384. PubMed ID: 33205391
[TBL] [Abstract][Full Text] [Related]
22. The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.
Okun E; Dikshtein Y; Carmely A; Saida H; Frei G; Sela BA; Varshavsky L; Ofir A; Levy E; Albeck M; Sredni B
FEBS J; 2007 Jun; 274(12):3159-70. PubMed ID: 17521335
[TBL] [Abstract][Full Text] [Related]
23. The immunomodulatory tellurium compound ammonium trichloro (dioxoethylene-O,O') tellurate reduces anxiety-like behavior and corticosterone levels of submissive mice.
Gross M; Stanciu E; Kenigsbuch-Sredni D; Sredni B; Pinhasov A
Behav Pharmacol; 2017 Sep; 28(6):458-465. PubMed ID: 28590303
[TBL] [Abstract][Full Text] [Related]
24. Effect of UVB and AS101 on interleukin-2 production and helper activity in psoriatic patients.
Shohat B; Kozenitzki L; David M; Albeck M; Sredni B
Nat Immun; 1993; 12(1):50-5. PubMed ID: 8094304
[TBL] [Abstract][Full Text] [Related]
25. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression.
Sredni B; Gal R; Cohen IJ; Dazard JE; Givol D; Gafter U; Motro B; Eliyahu S; Albeck M; Lander HM; Kalechman Y
FASEB J; 2004 Feb; 18(2):400-2. PubMed ID: 14656992
[TBL] [Abstract][Full Text] [Related]
26. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101.
Kalechman Y; Sredni B; Weinstein T; Freidkin I; Tobar A; Albeck M; Gafter U
J Am Soc Nephrol; 2003 Mar; 14(3):620-30. PubMed ID: 12595497
[TBL] [Abstract][Full Text] [Related]
27. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1.
Ferrick MR; Thurau SR; Oppenheim MH; Herbort CP; Ni M; Zachariae CO; Matsushima K; Chan CC
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1534-9. PubMed ID: 2016135
[TBL] [Abstract][Full Text] [Related]
28. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
[TBL] [Abstract][Full Text] [Related]
29. Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101.
Frei GM; Kremer M; Hanschmann KM; Krause S; Albeck M; Sredni B; Schnierle BS
Br J Dermatol; 2008 Mar; 158(3):578-86. PubMed ID: 18241275
[TBL] [Abstract][Full Text] [Related]
30. Synergism between AS101 and PMA in lymphokine production.
Sredni B; Kalechman Y; Shalit F; Albeck M
Immunology; 1990 Jan; 69(1):110-6. PubMed ID: 2107143
[TBL] [Abstract][Full Text] [Related]
31. The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma.
Kalechman Y; Shani A; Dovrat S; Whisnant JK; Mettinger K; Albeck M; Sredni B
J Immunol; 1996 Feb; 156(3):1101-9. PubMed ID: 8557985
[TBL] [Abstract][Full Text] [Related]
32. The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment.
Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
Exp Hematol; 1992 Dec; 20(11):1302-8. PubMed ID: 1493859
[TBL] [Abstract][Full Text] [Related]
33. Novel microwave-assisted synthesis of the immunomodulator organotellurium compound ammonium trichloro(dioxoethylene-O,O')tellurate (AS101).
Vázquez-Tato MP; Mena-Menéndez A; Feás X; Seijas JA
Int J Mol Sci; 2014 Feb; 15(2):3287-98. PubMed ID: 24566150
[TBL] [Abstract][Full Text] [Related]
34. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
[TBL] [Abstract][Full Text] [Related]
35. Immunologic effects of AS101 in the treatment of cancer patients.
Shani A; Tichler T; Catane R; Gurwith M; Rozenszajn LA; Gezin A; Levi E; Schlesinger M; Kalechman Y; Michlin H
Nat Immun Cell Growth Regul; 1990; 9(3):182-90. PubMed ID: 2370878
[TBL] [Abstract][Full Text] [Related]
36. Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.
Chiaverini L; Cirri D; Tolbatov I; Corsi F; Piano I; Marrone A; Pratesi A; Marzo T; La Mendola D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886853
[TBL] [Abstract][Full Text] [Related]
37. Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models.
Sredni B; Geffen-Aricha R; Duan W; Albeck M; Shalit F; Lander HM; Kinor N; Sagi O; Albeck A; Yosef S; Brodsky M; Sredni-Kenigsbuch D; Sonino T; Longo DL; Mattson MP; Yadid G
FASEB J; 2007 Jun; 21(8):1870-83. PubMed ID: 17314138
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulating tellurium compounds as anti-cancer agents.
Sredni B
Semin Cancer Biol; 2012 Feb; 22(1):60-9. PubMed ID: 22202556
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of radioprotection conferred by the immunomodulator AS101.
Kalechman Y; Gafter U; Barkai IS; Albeck M; Sredni B
Exp Hematol; 1993 Jan; 21(1):150-5. PubMed ID: 8417951
[TBL] [Abstract][Full Text] [Related]
40. Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101.
Sredni B; Rosenthal-Galili Z; Michlin H; Sobelman D; Seger Y; Blagerman S; Kalechman Y; Rager-Zisman B
Immunol Lett; 1994 Dec; 43(3):159-65. PubMed ID: 7721328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
